Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2d37fb8041db82befb3065684c82b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7694f7bfc6c576797858ab5eca314a97 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
filingDate |
2010-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9197756029537cdb1254f71c815597bd |
publicationDate |
2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011018515-A1 |
titleOfInvention |
Method of purifying pegylated proteins |
abstract |
The invention relates to a method of purifying PEGylated proteins ( which comprises anion exchange chromatography with an elution buffer comprising MgC12), in particular, but not exclusively vitamin K-dependent blood coagulation factors such as Factor VII (FVII), to proteins purified by said method and to the use of said purified proteins in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111801120-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010332959-B2 |
priorityDate |
2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |